 HAMPTON, N.J., July 13, 2021 GLOBE NEWSWIRE -- Celldex Therapeutics, Inc. Celldex or the Company Nasdaq: CLDX today announced the pricing of an underwritten public offering of 5,952,381 shares of its common stock at a public offering price of 42.00 per share. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 892,857 shares of common stock at the public offering price, less underwriting discounts and commissions. 